CH670451A5 - - Google Patents
Download PDFInfo
- Publication number
- CH670451A5 CH670451A5 CH4672/86A CH467286A CH670451A5 CH 670451 A5 CH670451 A5 CH 670451A5 CH 4672/86 A CH4672/86 A CH 4672/86A CH 467286 A CH467286 A CH 467286A CH 670451 A5 CH670451 A5 CH 670451A5
- Authority
- CH
- Switzerland
- Prior art keywords
- amino acid
- aliphatic
- polar
- atoms
- toxic peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/855—Proteins from animals other than mammals or birds
- Y10S530/856—Snakes; venom
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/801,019 US4731439A (en) | 1985-11-22 | 1985-11-22 | Snake venom growth arresting peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH670451A5 true CH670451A5 (es) | 1989-06-15 |
Family
ID=25179974
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH4672/86A CH670451A5 (es) | 1985-11-22 | 1986-11-21 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4731439A (es) |
| KR (1) | KR900006575B1 (es) |
| CN (1) | CN86108593A (es) |
| AU (3) | AU6556386A (es) |
| BE (1) | BE905790A (es) |
| CH (1) | CH670451A5 (es) |
| DE (1) | DE3639796A1 (es) |
| DK (1) | DK560986A (es) |
| ES (1) | ES2002915A6 (es) |
| FI (1) | FI864715A (es) |
| FR (1) | FR2590576A1 (es) |
| GB (1) | GB2185023B (es) |
| GR (1) | GR862788B (es) |
| IT (1) | IT1207580B (es) |
| LU (1) | LU86683A1 (es) |
| NL (1) | NL8602939A (es) |
| PT (1) | PT83790B (es) |
| SE (1) | SE8604991L (es) |
| YU (1) | YU199586A (es) |
| ZA (1) | ZA868849B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990015072A1 (en) * | 1989-06-07 | 1990-12-13 | Genentech, Inc. | Platelet aggregation inhibitors and related molecules |
| WO1991001740A1 (en) * | 1989-08-05 | 1991-02-21 | Varánusz Gm | Process for producing pharmacosmetics |
| US5232911A (en) * | 1990-01-03 | 1993-08-03 | Ventech Research Inc. | Mixture of a non-covalent heterodimer complex and a basic amphiphatic peptide as cytotoxic agent |
| US5766897A (en) * | 1990-06-21 | 1998-06-16 | Incyte Pharmaceuticals, Inc. | Cysteine-pegylated proteins |
| DE4433890C2 (de) * | 1994-09-22 | 1999-02-18 | Deutsches Krebsforsch | Konjugat aus einem Wirkstoff und einem nicht als körperfremd angesehenen, nativen Protein |
| SG129211A1 (en) * | 1997-11-06 | 2007-02-26 | Univ Singapore | Therapeutic molecules |
| BR0101088A (pt) * | 2001-03-19 | 2003-03-18 | Biolab Sanus Farmaceutica Ltda | Processo de isolamento e purificação de peptìdeos inibidores das vasopeptidases, com especificidade para o sìtio carboxìlico da enzima conversora da angiotensina, secretados pelas glândulas do veneno de serpentes (bpps), particularmente bothrops jararaca, ou produzidos endogenamente (evasins) possuindo ação vasodilatadora e anti-hipertensiva; processo de determinação da sequência de amido-ácidos dos peptìdios inibidores secretados pela glândula de veneno de serpentes (bpps) ou endógenos (evasins); processo de determinação da sequência de aminoácidos dos bpps por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca. processo de determinação da sequência de aminoácidos dos evasins por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca, processo de amplificação do cdna a partir das bibliotecas de cdna de pâncreas e/ou cérebro de serpentes, especificamente bothrops jararaca; processo de sìntese em fase sólida de peptìdeos inibidores das vasopeptidases com ação vasodilatadora e anti-hipertensiva, peptìdeos inibidores das vasopeptidases com ação anti-hipertensiva; utilização dos peptìdeos inibidores das vaso peptidases com ação vasodilatadora e anti-hipertensiva na obtenção de composições farmacêuticas; processo de determinação da atividade inibitória sobre as vasopeptidases e de atividade biológica sobre músculo liso, sistema cardiovascular e microcirculatório. |
| BRPI0501037B8 (pt) * | 2005-03-18 | 2021-07-27 | Fund De Amparo A Pesquisa Do Estado De Sao Paulo | uso de crotamina e composição |
| US20060234934A1 (en) * | 2005-04-15 | 2006-10-19 | Kilmon Joseph A | Composition and Method for Selective Cytostasis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5836308B2 (ja) * | 1977-02-10 | 1983-08-08 | 大塚製薬株式会社 | 抗体の製造方法 |
| US4220722A (en) * | 1978-02-10 | 1980-09-02 | Syva Company | Method for conjugating to polyamino compounds employing haloacyl groups and compositions prepared thereby |
| FR2437213A1 (fr) * | 1978-09-28 | 1980-04-25 | Cm Ind | Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation |
| US4500637A (en) * | 1982-07-19 | 1985-02-19 | The United States Of America As Represented By The Department Of Health And Human Services | Prevention of graft versus host disease following bone marrow transplantation |
-
1985
- 1985-11-22 US US06/801,019 patent/US4731439A/en not_active Expired - Fee Related
-
1986
- 1986-11-19 NL NL8602939A patent/NL8602939A/nl not_active Application Discontinuation
- 1986-11-19 BE BE0/217441A patent/BE905790A/fr not_active IP Right Cessation
- 1986-11-19 FI FI864715A patent/FI864715A/fi not_active Application Discontinuation
- 1986-11-20 GB GB8627710A patent/GB2185023B/en not_active Expired - Fee Related
- 1986-11-21 PT PT83790A patent/PT83790B/pt not_active IP Right Cessation
- 1986-11-21 SE SE8604991A patent/SE8604991L/xx not_active Application Discontinuation
- 1986-11-21 CH CH4672/86A patent/CH670451A5/de not_active IP Right Cessation
- 1986-11-21 ZA ZA868849A patent/ZA868849B/xx unknown
- 1986-11-21 IT IT8622425A patent/IT1207580B/it active
- 1986-11-21 DK DK560986A patent/DK560986A/da not_active Application Discontinuation
- 1986-11-21 DE DE19863639796 patent/DE3639796A1/de not_active Ceased
- 1986-11-21 ES ES8603138A patent/ES2002915A6/es not_active Expired
- 1986-11-21 AU AU65563/86A patent/AU6556386A/en not_active Abandoned
- 1986-11-21 FR FR8616270A patent/FR2590576A1/fr not_active Withdrawn
- 1986-11-21 YU YU01995/86A patent/YU199586A/xx unknown
- 1986-11-21 LU LU86683A patent/LU86683A1/fr unknown
- 1986-11-21 GR GR862788A patent/GR862788B/el unknown
- 1986-11-22 CN CN198686108593A patent/CN86108593A/zh active Pending
- 1986-11-22 KR KR1019860009886A patent/KR900006575B1/ko not_active IP Right Cessation
- 1986-11-24 AU AU65609/86A patent/AU6560986A/en not_active Abandoned
-
1990
- 1990-11-16 AU AU66675/90A patent/AU6667590A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NL8602939A (nl) | 1987-06-16 |
| GB2185023B (en) | 1990-08-29 |
| KR900006575B1 (ko) | 1990-09-13 |
| FR2590576A1 (fr) | 1987-05-29 |
| LU86683A1 (fr) | 1987-06-26 |
| BE905790A (fr) | 1987-05-19 |
| AU6560986A (en) | 1987-05-28 |
| ZA868849B (en) | 1987-07-29 |
| GR862788B (en) | 1987-03-26 |
| YU199586A (en) | 1988-06-30 |
| FI864715A0 (fi) | 1986-11-19 |
| DK560986A (da) | 1987-05-23 |
| IT1207580B (it) | 1989-05-25 |
| SE8604991D0 (sv) | 1986-11-21 |
| DK560986D0 (da) | 1986-11-21 |
| KR870005014A (ko) | 1987-06-04 |
| DE3639796A1 (de) | 1987-07-09 |
| IT8622425A0 (it) | 1986-11-21 |
| PT83790B (pt) | 1989-09-14 |
| FI864715A (fi) | 1987-05-23 |
| ES2002915A6 (es) | 1988-10-01 |
| SE8604991L (sv) | 1987-05-23 |
| PT83790A (en) | 1986-12-01 |
| AU6556386A (en) | 1987-05-28 |
| GB8627710D0 (en) | 1986-12-17 |
| AU6667590A (en) | 1991-03-28 |
| GB2185023A (en) | 1987-07-08 |
| US4731439A (en) | 1988-03-15 |
| CN86108593A (zh) | 1987-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0471701B1 (de) | Neue proteine mit tnf-hemmender wirkung und ihre herstellung | |
| DE69432629T2 (de) | Antikörper gegen beta-amyloid oder derivative davon und seine verwendung | |
| DE69017753T3 (de) | Tumor-Nekrosefaktor-Bindungsprotein II, seine Reinigung und spezifische Antikörper | |
| DE69028671T3 (de) | Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung | |
| Veenstra | Presence of corazonin in three insect species, and isolation and identification of [His7] corazonin from Schistocerca americana | |
| EP0021152B1 (de) | Verfahren zur immunologischen Bestimmung von Basalmembranmaterial, hierfür geeignete Basalmembranfragmente und Verfahren zu deren Herstellung, bzw. Gewinnung | |
| DE102005029845B4 (de) | Verfahren zur Diagnose von rheumatischen Erkrankungen | |
| EP0149468A2 (de) | Biologisch wirksame Substanz mit hormonellen Eigenschaften, Verfahren zu ihrer Herstellung und Verwendung von Histonen für medizinische Zwecke | |
| DE19637718A1 (de) | Rekombinante inaktive Core-Streptavidin Mutanten | |
| JPH0662677B2 (ja) | アンギオゲニン活性を有する精製蛋白及びその製造方法 | |
| DE69532436T2 (de) | Einzelkettenformen des clycoprotein-hormon-quartetts | |
| Weber et al. | Acetylated and nonacetylated forms of β-endorphin in rat brain and pituitary | |
| DE69632828T2 (de) | Peptide des antisekretorischen faktors, welches krankhafte permeabilitätsanderungen reguliert | |
| WO1999015651A1 (de) | Synthetische polypeptide zur diagnose und therapie von prionerkrankungen | |
| CHRISTOFIDES et al. | Distribution of PHI in the rat brain | |
| CH670451A5 (es) | ||
| Huang et al. | RF-amide peptides isolated from the midgut of the corn earworm, Helicoverpa zea, resemble pancreatic polypeptide | |
| DE19961350A1 (de) | Verfahren zur Bestimmung der Parathormon-Aktivität in einer menschlichen Probe | |
| EP0298210B1 (de) | Verfahren zur selektiven immunologischen Bestimmung von intaktem Prokollagen Peptid (Typ III) und Prokollagen (Typ III) in Körperflüssigkeiten und Mittel zu dessen Durchführung | |
| DE60124915T2 (de) | Synthetische peptide gegen neurologische krankheiten | |
| DE60318749T2 (de) | Paralytisches peptid von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten | |
| DE60112424T2 (de) | Protonen-abhängiges na+-kanal hemmendes polypeptid | |
| DE102004051014A1 (de) | Chemisch modifizierte Peptidanaloga | |
| DE3645095C2 (de) | Antikörper | |
| DE3014582C2 (es) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |